Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−4.52 EUR
−238.73 M EUR
81.76 M EUR
44.68 M
About REGENXBIO Inc.
Sector
CEO
Curran M. Simpson
Headquarters
Rockville
Website
Founded
2008
FIGI
BBG00B0LV7S8
REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of RB0 is 8.05 EUR — it has increased by 2.52% in the past 24 hours. Watch REGENXBIO INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange REGENXBIO INC stocks are traded under the ticker RB0.
RB0 stock has risen by 12.41% compared to the previous week, the month change is a 9.40% rise, over the last year REGENXBIO INC has showed a −33.47% decrease.
We've gathered analysts' opinions on REGENXBIO INC future price: according to them, RB0 price has a max estimate of 50.28 EUR and a min estimate of 21.27 EUR. Watch RB0 chart and read a more detailed REGENXBIO INC stock forecast: see what analysts think of REGENXBIO INC and suggest that you do with its stocks.
RB0 stock is 5.59% volatile and has beta coefficient of 2.45. Track REGENXBIO INC stock price on the chart and check out the list of the most volatile stocks — is REGENXBIO INC there?
Today REGENXBIO INC has the market capitalization of 401.60 M, it has increased by 6.14% over the last week.
Yes, you can track REGENXBIO INC financials in yearly and quarterly reports right on TradingView.
REGENXBIO INC is going to release the next earnings report on Mar 4, 2025. Keep track of upcoming events with our Earnings Calendar.
RB0 earnings for the last quarter are −1.05 EUR per share, whereas the estimation was −1.01 EUR resulting in a −4.25% surprise. The estimated earnings for the next quarter are −1.09 EUR per share. See more details about REGENXBIO INC earnings.
REGENXBIO INC revenue for the last quarter amounts to 21.73 M EUR, despite the estimated figure of 21.22 M EUR. In the next quarter, revenue is expected to reach 22.69 M EUR.
RB0 net income for the last quarter is −53.53 M EUR, while the quarter before that showed −49.47 M EUR of net income which accounts for −8.20% change. Track more REGENXBIO INC financial stats to get the full picture.
No, RB0 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 6, 2025, the company has 344.00 employees. See our rating of the largest employees — is REGENXBIO INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. REGENXBIO INC EBITDA is −204.11 M EUR, and current EBITDA margin is −277.93%. See more stats in REGENXBIO INC financial statements.
Like other stocks, RB0 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade REGENXBIO INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So REGENXBIO INC technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating REGENXBIO INC stock shows the sell signal. See more of REGENXBIO INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.